These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1858708)

  • 21. Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy.
    Gross L; Brotman M
    Ann Intern Med; 1970 Jan; 72(1):95-6. PubMed ID: 5410402
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypoprothrombinemia and bleeding associated to treatment with cholestyramine (author's transl)].
    Acuña R; González Ceron M
    Rev Med Chil; 1977 Jan; 105(1):27-8. PubMed ID: 882747
    [No Abstract]   [Full Text] [Related]  

  • 23. Life-threatening metabolic acidosis from cholestyramine in an infant with renal insufficiency.
    Pattison M; Lee SM
    Am J Dis Child; 1987 May; 141(5):479-80. PubMed ID: 3578154
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypoprothrombinemic hemorrhage due to cholestyramine therapy.
    Shojania AM; Grewar D
    CMAJ; 1986 Mar; 134(6):609-10. PubMed ID: 3948073
    [No Abstract]   [Full Text] [Related]  

  • 25. Addition to labeling of cholestyramine.
    FDA Drug Bull; 1985 Apr; 15(1):7-8. PubMed ID: 3858190
    [No Abstract]   [Full Text] [Related]  

  • 26. Acidosis and extreme hyperkalemia associated with cholestyramine and spironolactone.
    Zapater P; Alba D
    Ann Pharmacother; 1995 Feb; 29(2):199-200. PubMed ID: 7756724
    [No Abstract]   [Full Text] [Related]  

  • 27. Intestinal obstruction associated with cholestyramine therapy.
    Merten DF; Grossman H
    AJR Am J Roentgenol; 1980 Apr; 134(4):827-8. PubMed ID: 6767374
    [No Abstract]   [Full Text] [Related]  

  • 28. Malabsorption of thyroid hormone with cholestyramine administration.
    Rosenberg R
    Conn Med; 1994 Feb; 58(2):109. PubMed ID: 8004946
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-carotene, carotenoids, and disease prevention in humans.
    Mayne ST
    FASEB J; 1996 May; 10(7):690-701. PubMed ID: 8635686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cuemid.
    Med Lett Drugs Ther; 1965 Jun; 7(12):45-6. PubMed ID: 5826749
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea.
    Heaton KW; Lever JV; Barnard D
    Gastroenterology; 1972 Apr; 62(4):642-6. PubMed ID: 5020877
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cholestyramine in hepatology].
    Hecht Y
    Med Chir Dig; 1978; 7(8):705-8. PubMed ID: 570624
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hypercholesteremia with cholestyramine, a bile acid sequestering resin.
    Casdorph HR
    Vasc Dis; 1967 Oct; 4(5):305-8. PubMed ID: 6051118
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancers of the nasopharynx and oropharynx and formaldehyde exposure.
    Tamburro CH; Waddell WJ
    J Natl Cancer Inst; 1987 Sep; 79(3):605. PubMed ID: 3476796
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of chronic non-specific enteritis in infants and small children with cholestyramine].
    Weigert SR
    Kinderarztl Prax; 1980 Aug; 48(8):412-5. PubMed ID: 7431737
    [No Abstract]   [Full Text] [Related]  

  • 36. The lipid research clinics trial.
    Lancet; 1984 Mar; 1(8377):633-4. PubMed ID: 6142340
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholestyramine.
    Thompson WG
    Can Med Assoc J; 1971 Feb; 104(4):305-9. PubMed ID: 5544698
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypolipidemic agents and gallstones.
    Med Lett Drugs Ther; 1977 Jun; 19(11):46. PubMed ID: 865410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum-lipid reducing principles--possibilities for treatment. 7. Ion exchangers (cholestyramine)].
    Nikkilä EA
    Lakartidningen; 1970 Dec; 67():Suppl IV:83+. PubMed ID: 5511955
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.